Off-Label Use and Promotion Protected by Federal Court (Orthopedics This Week)
Federal appeals court panel said on Monday, December 3, that prohibiting discussions between physicians and medical sales reps about off-label use of their products violates the First Amendment right to free speech.
It's also bad science, does not promote the public's health and stifles innovation. Off-label use is often the standard of care medicine.
"It only furthers the public interest to ensure that decisions about the use of prescription drugs, including off-label usage, are intelligent and well-informed," wro...
The Orthopedics Industry 
